Panacea Biotech Fact Sheet, Panacea Biotech Financial Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Panacea Biotech Fact Sheet    (PANB)


Revealing Tomorrow: The Great Indian Wealth Project


Here is the latest financial fact sheet of Panacea Biotech. For more details, see the Panacea Biotech quarterly results and Panacea Biotech share price and chart. For a sector overview, read our pharmaceuticals sector report.

PANACEA BIOTECH Price History

Price Rs 380.5
Mkt Cap Rs m 23,306
Vol '000 175.0
P/E X 17.1
P/CF X 24.6
EPS (TTM) Rs 22.3
% ch % 1.4
No. of shares m 61.25
% ch week % 18.8
% ch 1-mth % 47.1
% ch 12-mth % 132.8
52 week H/L Rs 407.2/141.0
(As on May 14, 2021 (Close))
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

PANACEA BIOTECH Financials

No. of Mths
Year Ending
12
Mar-15
*
12
Mar-16
*
12
Mar-17
*
12
Mar-18
*
12
Mar-19
*
5-Yr Chart
Click to enlarge
PANACEA BIOTECH EQUITY SHARE DATA
High Rs219183178364354 
Low Rs958486129138 
Sales per share (Unadj.) Rs112.2106.688.896.874.6 
Earnings per share (Unadj.) Rs-17.4-3.0-6.7-12.06.7 
Diluted earnings per shareRs-17.4-3.0-6.7-12.06.7 
Cash flow per share (Unadj.) Rs-6.49.04.4-2.715.5 
Dividends per share (Unadj.) Rs00000 
Adj. dividends per shareRs0.000.000.000.000.00 
Dividend yield (eoy) %00000 
Book value per share (Unadj.) Rs74.365.958.150.457.2 
Adj. book value per shareRs74.365.958.150.457.2 
Shares outstanding (eoy) m61.2561.2561.2561.2561.25 
Bonus / Rights / Conversions  ----- 
Price / Sales ratio x1.41.31.52.53.3 
Avg P/E ratio x-9.0-44.7-19.8-20.536.8 
P/CF ratio (eoy) x-24.514.829.9-92.515.9 
Price / Book Value ratio x2.12.02.34.94.3 
Dividend payout %00000 
Avg Mkt Cap Rs m9,6078,1718,07915,10115,061 
No. of employees `0002.72.52.32.52.3 
Total wages/salary Rs m1,3601,4201,4811,5161,471 
Avg. sales/employee Rs Th2,537.62,613.42,406.12,401.91,973.6 
Avg. wages/employee Rs Th502.1568.3655.1614.2635.6 
Avg. net profit/employee Rs Th-393.3-73.2-180.8-298.2176.8 
PANACEA BIOTECH INCOME DATA
Net Sales Rs m6,8726,5315,4405,9284,567 
Other income Rs m2852044667845 
Total revenues Rs m7,1576,7345,9066,0064,612 
Gross profit Rs m4391,1176248632,030 
Depreciation Rs m672733680573540 
Interest Rs m1,0451,2731,0091,0061,048 
Profit before tax Rs m-994-686-599-637486 
Minority Interest Rs m1823000 
Prior Period Items Rs m-582300 
Extraordinary Inc (Exp) Rs m04977700 
Tax Rs m3119-1109977 
Profit after tax Rs m-1,065-183-409-736409 
Gross profit margin %6.417.111.514.644.4 
Effective tax rate %-3.1-2.818.3-15.515.9 
Net profit margin %-15.5-2.8-7.5-12.49.0 
PANACEA BIOTECH BALANCE SHEET DATA
Current assets Rs m5,2574,9915,3345,6032,415 
Current liabilities Rs m7,0604,6575,8816,9109,077 
Net working cap to sales %-26.25.1-10.1-22.0-145.9 
Current ratio x0.71.10.90.80.3 
Inventory Days Days16517221220665 
Debtors Days Days5269958471 
Net fixed assets Rs m12,99812,32110,3689,9418,333 
Share capital Rs m6161616161 
"Free" reserves Rs m4,4883,9743,4963,0263,443 
Net worth Rs m4,5494,0363,5573,0873,504 
Long term debt Rs m7,2307,8577,1415,707461 
Total assets Rs m19,30518,03018,00116,07613,755 
Interest coverage x00.50.40.41.5 
Debt to equity ratio x1.61.92.01.80.1 
Sales to assets ratio x0.40.40.30.40.3 
Return on assets %-0.16.03.31.710.6 
Return on equity %-23.4-4.5-11.5-23.811.7 
Return on capital %0.19.34.64.238.7 
Exports to sales %30.936.033.724.020.9 
Imports to sales %20.49.514.317.58.1 
Exports (fob) Rs m2,1252,3481,8321,424954 
Imports (cif) Rs m1,3996197801,040372 
Fx inflow Rs m2,3992,6981,9981,6001,203 
Fx outflow Rs m1,6739258981,131467 
Net fx Rs m7261,7731,101469736 
PANACEA BIOTECH CASH FLOW
From Operations Rs m 372 907 1,307 1,180 1,049 
From Investments Rs m -374 164 -258 553 -54 
From Financial Activity Rs m -7 -1,174 -1,070 -1,644 -1,011 
Net Cashflow Rs m -9 -103 -21 90 -20 
* Results Consolidated
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Share Holding

Indian Promoters 74.5%
Foreign collaborators 0.0%
Indian inst/Mut Fund 0.6%
FIIs 1.3%
ADR/GDR 0.0%
Free float 23.6%
Shareholders 10,259
Pledged promoter(s) holding 35.1%
 

Company Information

REGD OFF Ambala - Chandigarh Highway, Lalru, Punjab - 140 501
E-MAIL companysec@panaceabiotec.com WEB www.panaceabiotec.com
TELEPHONE (011) 4157 8024 FAX (011) 4167 9070
SECTOR PHARMACEUTICALS GROUP MISCELLANEOUS
TR AGENT Skyline Financial, D-153 A, Ist Flr., Okhla Indl. Area, Phase-I, New Delhi-20
AUDITOR S. R. Batliboi & Co.
CHM: Soshil Kumar Jain COMP SEC: Vinod Goel (GM-Legal) YEAR OF INC: 1985 BSE CODE: 531349 FV (Rs): 1 DIV YIELD (%): -

Read: PANACEA BIOTECH 2017-18 Annual Report Analysis

More Pharmaceuticals Company Fact Sheets:   NOVARTIS  JUBILANT PHARMOVA   ELDER PHARMA  SANOFI INDIA  J.B.CHEMICALS  

Compare PANACEA BIOTECH With:   NOVARTIS  JUBILANT PHARMOVA   ELDER PHARMA  SANOFI INDIA  J.B.CHEMICALS  

Compare PANACEA BIOTECH With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  




Today's Market

Sensex, Nifty End Flat; Asian Paints, UPL & ITC Among Top Gainers(Closing)

Indian share markets witnessed volatile trading activity throughout the day today and ended on a flat note.

Views on news

Dr Reddy's Lab Shares Fall As Earnings Miss Estimates. What Next? (Views On News)

May 14, 2021

The company's board recommended a final dividend of Rs 25 for financial year 2020-21.

What's Behind the Rally in Pharma Stocks? (Views On News)

May 11, 2021

The second wave of Covid has given a new lease of life to pharma stocks.

Why Did Alembic Pharma Shares Fall Today? (Views On News)

May 5, 2021

Covid-led supply disruptions of API fuel Alembic Pharma's global prospects.

More Views on News

Most Popular

Is Intraday Trading For You? (Fast Profits Daily)

May 13, 2021

Do you think you have what it takes to be an intraday trader? Find out in this video.

My Secret to Find Breakthrough Stocks (Fast Profits Daily)

May 7, 2021

I've used this trading technique for many years with great success. I'm sharing it with you today.

Are the Stock Markets Deaf to Covid Agony? (Profit Hunter)

May 6, 2021

Why are markets discounting the economic impact of Covid?

The Key to Profit from India's EV Revolution (Profit Hunter)

May 7, 2021

Stocks you must consider investing in before buying your first electric vehicle.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

TRACK PANACEA BIOTECH

  • Track your investment in PANACEA BIOTECH with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON PANACEA BIOTECH

PANACEA BIOTECH - AUROBINDO PHARMA COMPARISON

COMPARE PANACEA BIOTECH WITH

MARKET STATS